Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
tld-1433 (1 trial)
tld1433 (1 trial)
Urinary Bladder Neoplasms (Phase 2)
Trials (2 total)
Trial APIs (2 total)